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1708-1I Medi.~-~ndLong-T~~~~~~~dYn~ i ~*fie~
Biatrial and Bicaval Otthotopic Heart
Transplantation
K. Mayer, A. Kunzli, H.P. Brunner-Le Rocca, M. Turina, W. Kiowski. Division
of Carrtiologyand Clinic for Cardiovascular Surge~, University Hospital,
Zurich, Switzerland
Two principle surgical techniques are used for orthotropicheart transplanta-
tion: the standard technique with biatrial anastomosis and the technique with
bicaval anastomosis. From the date of technicsl switch in 1990 from biatrlal
to bicaval anastomosis we analysed echocerdiographic and hemodynamic
results of 45 patients backward with biatrial and 45 patients forward with
biceval anastomosis followed-up at our institution with a minimum suwival
of 1 year. Hemodynamic parameters were assessed yearly by right heart
catheterization and the presence of (moderate) tricuspid regurgitation by
echocardiography. Statistical analysis was performed for the first (A) and for
the last assessment (B).
A B
biatrial blcsval biatrial bicevai
92& 12 93* 12 (p= 0.92) 90•11 88* 12 (p= 0,11)
UP 3*2 3*3 (p= 0.23) 4*3 4*3
PAP 14+4
(p= 0.97)
16&6 (p= 0.17) 15*4 1S+6
PCWP 7*4 6&7
(P= 0.s7)
(p= 0,18) s&4 9+6
MAP 99 i 10
(P= 0.25)
101 *13 (p= 0.03) 97+ 11
cl
98* 16 (p= 0.01)
3.1 * 0.s 3.1 +0.7 (p= 0.79) 3.1 &O.8 3.2+ 0.6 (p= 0.21)
EF 67+ 9 64+ 11 (p= 0.34) 88+9 69+6
PVR 107*51
(P= 0.85)
109+ 65 (p= 0.59) 115+58 124+59 (p= 0.74)
SVR 1447+ 354 1386+ 321 (p= 0.47) 1333+ 361 1315+276 (p= 0.271
TI 6% 5% (p= 0.93) 6% 5% (P= 0.93)
Conclusion: These data suggest that the technical difference between
biatrial and bicaval anastomosis does not play a decisive role for long-term
hemodynamic outcome after orthotropicheart transplantation.
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/708-21 Evidence OfVentricUlar~ascU,ar UncOUpl,nginSO,,d
Organ Transplant Recipients with HypeRenslon
H.O. Ventura, R.V. Milani, M.R. Mehra, D. Lucini, F.W.Smart,
D.D. Stapleton, M. Pagani, J.P. Murgo. Ochsner Medice/ Institutions, New
Orleans, LA, USA, Univeffiita diMilano, Italy
Despite the high incidence of hypertension associated with the use of cy-
closporine, little is known of the effects of this agent on ventricular/vascular
coupling in patients (pts) undergoing solid-organ transplantation (TP). Thus,
systemic arterial compliance (SAC) was measured by tonometry using the
first derivative of the blood pressure diastolic decay in 23 pts following organ
transplantation [10 with orthotropicheart transplantation; 13 with solid organ
transplantation on similar doses of cyclosporine (240+38 vs 250 + 48 mg;
p = ns)] and compared to 19 normal subjects and 10 pts with essential hy-
pertension. Systemic hemodynamics (mean arterial pressure and heart rate)
were measured in all patients.
Resu/ts: (mean& SEM)
Normal EH SOT OHT
Aga (years) 40+ 3 47* 3 48*3 49• 3
MAP (mmHg) 88*2 110 *2* 109 i 2* 11O*2*
HR (bpm) 64& 2 76& 5 74& 3 101 *3**
SvstemicArterialComcdiance(units) 4.2 + 0.5 3.1 + 0.6 2.5+ 0.3” 0,4S k 0.1”
EH = essentialhypertension;SOT= Non-cerdiacsolidorgantransplant;OHT= orthotropic
heart transplant;MAP = mean arterial presaure:. p = 0.001 vs normals;““p = 0.003 va
normal,EH and SOT
Atthesame recipent age, level of arterial presaureand cyclosporine dose,
pts following cardiac transplantation had the lowest arterial compliance and
younger aged hearts compared to pts with solid organ transplantation (24+
7 yrs Vs 4a + 3 yre, p = 0.01).
h’tferences.’1)Cyclosporine-induced hypertension is associated with im-
paired ventricular vascular coupling evidenced by a decrease in arterial
compliance. 2) The lowest arterial compliance in cardiac transplantation may
be due to the additive effaef of cardiac denewation on arterial regulation
and/or structural changes in the peripheral vaeculature secondary to long-
standing heart failure as well as the mismatch between the older vasculature
and younger hearts.
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F[ MY~ardiai~ef~n~,onA~aoc,atedwithCentral
Nervous System Catastrophe
KS. Dujardin, R.B. McCully, E.F,Wijdicks, H.D. Tazelaar, L.J. Olson,
C.G. McGregor,J.B. Seward. Mayo Clinic Rooheste< MN, USA
Ssckground: Myocardial dysfunction (Mdys) is associated with severe brain
injury (Bl); its frequeney and relationship to the etiology of BI are unknown.
Methods: To characterize this phenomenon, we reviewed the clinical
course, head computed tomography (CT) and echcoardiographic (Echo)
data of 68 patients (pts) with acute BI and brain death who were potential
heart donors.
Resufts: Echo Mdys was present in 28 (420A)and absent in 38 pts. There
were no differences between these two groups with regard to age, gender,
etiology of Bl, its severily on CT, and peri-Echo blocd preasure, heart rate
and dopamine usage. Ventricular arrhythmias were more Common (84°A vs
O%,p < 0.01) in the Mdys pts. Characteristics of the Mdys pts according to
etiology of BI are tabled below. Ten pte had histologic data; only 3 of 10 pts
had evidence of acute myocyte injury on light microsmpy.
SAH/lCH (n = 8) Trauma (n= 17) Other (n= 3)
Age, yrs 44* 9* 25+ 12* 35 ~ 6
Ilms from BI to dsath, hrs 26& 26 31 i 38 136 + 184
Echo EieetionFraction.% 34+ 10 36+ 16 32* 14.-—
Regionaldysfunction,n (%) 8 (100)t 8(63) 1 (33)
GlobalDysfunction,n (%) o (o)* 6 (47)* 2(87)
tln 5 SAH/lCH patisnfsthe a~x was sparedhormal, “P -=0.01
Cone/us/ens: Mdys after severe BI 1) is common and associated with
ventricular arrhythmias, 2) is regional with subarachnoidhwecerebrel hem-
orrhage (SAH/lCH) but variable (regional or global) with head trauma and 3)
is often not aceompeniad by acute histologic changee.
FI cardiacTransP,an@tioninchagaS,C
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Cardiomyopathy: Can you do it? Should you do it?
A. Carvalho, D. Almeida, J.N. Branco, J.E. Azevedo, E. Buffolo, E. Martinez.
Esoola Pau/ista de Medicina, UNIFESR Sgo Paulo, Brazil
Cardiac transplantation (Tx) in Chagas’ diseaee haa been aescciated with
a high incidence of neoplasms and T. cruzii reactivation, as well aa high
mortality. A recent infectious diaease textbook says you shouldn’t perform
hearl Tx in Chagas’ disease. Since January 93 we prospectively studied
33 consecutive heart Tx, 15 in Chagas’ (Group I - Gl) and 18 in non-
Chagasic cardiomyopathy (Group II - Gil). Because we ccmeideredChagas’
to be an infectious disease with immunoeuppreesion condition of its own GI
utilized less cyclosporfn (4.88+ 0.57 x 5.35+ 0.50 mgik~day) than Gll and
prednisone was discontinued 90 daya attar heart Tx. Azathioprine was the
same in Gi and Gil. Both groups were followed-up for 12.8 + 8.6 months.
Results:
Infeetion Rejeetion T. cruzii Late Echo Deatha
(episode/pi)
26 mo
reactivation ejeetionfraction aurvivai
GI 0,33 0.S6 0.2 72,3 3 80.0%
Gll 0.55 1,16 - 77.7 4 77.s%
p value NS for all
Nobody developed any neoplasm during our follow-up paricd. Conclu-
sions: Group I patients who receive heart transplantation have a low T. cruzii
reactivation rate. Our Chagasic petiante have the same survival expectancy
as group II patients. Our results eeem to indicate that you can and that
you should perform heart Tx in Chagasic patients, contrary to what has
been recently recommended in the literature, as long as you decreaae your
conventional immunosuppression protocol.
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El7085 Is Tacrolimus (FK508) Superior to Cyclosporine for
Primsry Immunosuppression After Heart
B.M. Meiser, P.Uberfuhr, A. Fuchs, S. Martin, W. v. Scheidt, C. Angermann,
E. Kreuzer, B. Reichart. University of Munich, Munich, Germany
The efficacy of FK506 and CSAaa primary immunosuppresaante aftar heart
transplantation (HTx) were compared in a controlled randomized clinical
